Currently, Abbvie Inc [ABBV] is trading at $173.02, down -1.35%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ABBV shares have lost -0.77% over the last week, with a monthly amount glided 4.05%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Daiwa Securities downgraded its rating to Neutral on December 05, 2024, and kept the price target unchanged to $180. On November 22, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $206 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $205 on November 15, 2024. Argus upgraded its rating to a Buy. Bernstein started tracking with a Mkt Perform rating for this stock on October 17, 2024, and assigned it a price target of $203. In a note dated June 05, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $185.
This stock has fluctuated between a low of $151.29 and a high of $207.32 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $211.2 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $173.02 at the most recent close of the market. An investor can expect a potential return of 22.07% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Trailing Twelve Months sales for Abbvie Inc [NYSE:ABBV] were 55.53B which represents 3.83% growth. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.66 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of11.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 171.73 points at the first support level, and at 170.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 175.41, and for the 2nd resistance point, it is at 177.79.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abbvie Inc [NYSE:ABBV] is 0.65. Further, the Quick Ratio stands at 0.54, while the Cash Ratio is 0.17. Considering the valuation of this stock, the price to sales ratio is 5.51, the price to book ratio is 50.69 and price to earnings (TTM) ratio is 60.34.
Transactions by insiders
Recent insider trading involved Buckbee Kevin K, SVP, CONTROLLER, that happened on Dec 16 ’24 when 1800.0 shares were sold. Officer, Buckbee Kevin K completed a deal on Dec 16 ’24 to buy 1800.0 shares. Meanwhile, Officer Hudson Thomas J bought 49170.0 shares on Aug 08 ’24.
